Automation for higher throughput in protein expression: visions, facts and fictions

doi:10.1186/1475-2859-5-S1-P60

Microbial Cell Factories

Volume 5
Suppl 1

Viewing options:

Abstract
Full text
PDF (235KB)

Related literature:

Articles citing this article
on Google Scholar
Other articles by authors
on Google Scholar

Mahnke M
Schlaeppi JM
Pouliquen Y
Barys L
Rolvering C
Henke M
Schmitz R
Geisse S
Kolbinger F

on PubMed

Mahnke M
Schlaeppi JM
Pouliquen Y
Barys L
Rolvering C
Henke M
Schmitz R
Geisse S
Kolbinger F
Related articles/pages
on Google

on Google Scholar

Tools:

Post to:

This article is part of the supplement: The 4th Recombinant Protein Production Meeting: a comparative view on host physiology .

Poster Presentation

Automation for higher throughput in protein expression: visions, facts and fictions

Marion Mahnke¹, Jean Marc Schlaeppi¹, Yann Pouliquen¹, Louise Barys², Catherine Rolvering³, Mario Henke¹, Rita Schmitz¹, Sabine Geisse¹ and Frank Kolbinger¹

¹Biomolecules Production Unit, Novartis Institutes for Biomedical Research, Basle, Switzerland

²Oncology Department, Novartis Institutes for Biomedical Research, Basle, Switzerland

³Faculty of Science, Technology and Communication, University of Luxembourg, Luxembourg

corresponding author email

from The 4th Recombinant Protein Production Meeting: a comparative view on host physiology
Barcelona, Spain. 21–23 September 2006

Microbial Cell Factories 2006, 5(Suppl 1):P60doi:10.1186/1475-2859-5-S1-P60


Published:	10 October 2006

First paragraph (this article has no abstract)

Down-scaling, parallelization and automation are new trends in the field of recombinant protein expression in the post genomic era [1-3]. During the past years many companies and academic institutions have heavily invested in process and automation technologies. Does this trend keep its promise? Can post genomic protein production issues be overcome with few automated processes?